Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Mol Psychiatry. 2022 Oct 17;28(1):298–328. doi: 10.1038/s41380-022-01819-w

Table 4.

Randomized controlled trials of exercise as an adjunct to standard care for major depressive disorder

Trial Depression diagnosis criteria and type Sample Interventions Study Duration Treatment arms (n) Outcomes
Adherence Drop-outs n(%) Remission Rate %
Martinsen et al., 198565 DSM

Major
Males and females, 17–60y/o, admitted to the hospital, met criteria for depression
Exclusion: psychosis, physical contraindications to exercise
n=49
40±NR y/o
NR% males
Inpatient setting

AEx: 1hr at 50–70% of VO2max

TAU: Individual psych, OT, pharm
Pharm n(%)
AEx: 9(NR%)
CON: 14(NR%)

CON: 1hr of OT
9 weeks

AEx: 3d/wk/9wks
(27 supervised group sessions)


CON: 3d/wk/9wks
(27 supervised group sessions)
AEx + TAU: (n=28) NR 4(14.1%) NR
CON + TAU (n=21) NR 2(9.5%) NR
Veale et al., 199266
Study 1
CIS

Major
Males and females, 18–60y/o, CIS ≥17 and depression severity ≥2, concurrent treatment (pharm, psych, etc.) permitted
n=83
Study 1:
Age and Sex: NR
Study 1 & 2:
35.5±NR y/o
36% males
Outpatient setting

AEx: Stretching warm-up, running program. Duration and intensity NR

TAU: Pharm and/or psych
Pharm, Psych (%):
AEx: 45%, NR
CON: 34%, NR

CON: TAU only
12 weeks

AEx: 3d/wk/12wk
(36 supervised group sessions)

TAU: NR

CON: No sessions beyond assessments
AEx + TAU (n=48) AEx: NR
TAU: NA
12(25.0%) Remission: NR
Change in BDI: 30% reduction
CON (n=35) NA 6(17.2%) Remission: NR
Change in BDI: 32% reduction
Veale et al., 199266
Study 2
CIS

Major
Males and females, 18–60y/o, CIS ≥17 and depression severity ≥2, concurrent treatment (pharm, psych, etc.) permitted
n=41
Study 2:
Age and Sex: NR
Study 1 & 2:
35.5±NR y/o
36% males
Outpatient setting

AEx: Stretching warm-up, running program. Duration and intensity NR

LO-PA: Relaxation, stretching, and yoga. Duration and intensity NR

TAU: Pharm and/or psych
Pharm, Psych (%):
AEx: 41%, NR
LO-PA: 11%, NR
12 weeks

AEx: 3d/wk/12wk
(36 supervised group sessions)

LO-PA: 3d/wk/12wk
(36 supervised group sessions)

TAU: NR
AEx + TAU (n=63) AEx: NR
TAU: NA
17(26.9%) Remission: NR
Change in BDI: 35% reduction
LO-PA + TAU (n=26) LO-PA: NR
TAU: NA
4(15.8%) Remission: NR
Change in BDI: 40% reduction
Knubben et al., 200767 DSM-IV

Major
Males and females, 20–70y/o, BRMS >12, admitted to inpatient facility, ambulatory
Exclusion: associated organic disease, schizophrenic symptoms, epilepsy, ECT referral
n=41
Age: NR
44.7% males
Inpatient setting

AEx: 30mins of interval (1:1) walking (5 reps of 3mins at 80% APHRM and Borg RPE 13–14 and 3mins at half speed of high interval)

TAU: Pham, sleep deprivation

CON: 30mins light stretching of calves, thighs, back, shoulders, and pectoral muscles (20s hold, 40s rest)
10 days

AEx:1x/d/10d
(10 supervised sessions)

CON: 1x/d/10d
(10 supervised sessions)
AEx + TAU (n=20) NR 1(5.0%) Remission: NR
Response: 65%

Change in BRMS: 36% reduction
CON + TAU (n=18) NR 2(11.1%) Remission: NR
Response: 22%

Change in BRMS: 18% reduction
Krogh et al., 200968 ICD-10 /DSM-IV-MDI

Unipolar Major
Males and females, 18–55y/o, referred by medical doctor or psychologist and met ICD-10 criteria,
Exclusion: alcohol or substance abuse, acute suicidal risk, psychotic symptoms, medical conditions that contraindicated physical exercise, been on sick leave for >24mos, exercising >1hr/wk
n=165
38.9±9.5y/o
26.1% males
Outpatient setting

P-AEx: 90mins of interval training; initially 2mins on: 2mins rest at 70% MHR and progress to 3mins on:1min rest at 89% MHR. AEx included cycling, running, stepping, abdominal exercises, rowing, trampoline, step bench, jump rope, and Ski Fitter

PREx: 90mins for 2–3sets x12 reps at 50% 1-RM progressed to 2-3 sets x8-10 reps at 75% 1-RM. 6 exercises on machines (leg extension, leg press, total abdominal, lower back, chest press, vertical traction) and 3 with weights (calves, arm abductors, and triceps)

Relax: 90mins of light activity at Borg RPE ≤12; 20–30mins exercise on mattresses or back massage, 10–20mins of light balance activities, and 20–30mins of supine relaxation.

TAU: Pharm and/or psych
Pharm, Psych (%):
P-AEx:
64.6%, 47.9%
PREx:
66.0%, 48.9%
Relax:
52.4%, 47.6%
16 weeks

All groups: 2d/wk/16wks
(32 supervised group sessions)

TAU: NR
P-AEx + TAU (n=55) P-AEx: 56.2%
TAU: NA
8(14.6%) 40.4%
PREx + TAU (n=55) PREx: 50.6%
TAU: NA
7(12.7%) 29.2%
Relax + TAU (n=55) Relax: 32.8%
TAU: NA
13(23.6%) 31.7%
Doose et al., 201569 ICD-10
CIS


ICD-10 codes: F32.0/1/2, F33.0/1/2

Major
Males and females, 18–65y/o, HAM-D ≥25, admitted to inpatient facility, met ICD-10 criteria, not involved in any other PA during hospitalization
Exclusion: severe depressive episode (ICD-10: F32.3 or F33.3), psychotic symptoms, psychiatric comorbidities (bipolar, schizophrenia, drug addiction), pregnancy, change in psych or pharm treatment, beginning psych, relevant orthopedic disease, relevant surgery in past 6mos, acute general disease (infectious disease, anemia, cancer), poorly controlled diabetes, severe cardiovascular disease, enrolling in other clinical trial
n=46
48±NR y/o
37.0% males
Inpatient setting

AEx: 10–15min warm-up; 30–45mins walking or running at self-selected intensity (mean ~12 on Borg RPE); 10–15min cool-down


TAU: Pharm and/or psych
Pharm, Psych (%):
AEx: 50%, 53.3%
CON: 75%, 68.8%

CON: TAU while waitlist
8 weeks

AEx: 3d/wk/8wks
(24 supervised group sessions)

TAU: NR

CON: Only pre- and post-intervention assessment sessions
AEx + TAU (n=30) AEx: 58%
TAU: NA
7(23.3%) 63.3%
CON (n=16) NA 4(25.0%) 0%
Hallgren et al., 201570 DSM-IV-MINI

Major, anxiety, comorbid anxiety
Males and females, ≥18y/o, PHQ-9 >9,
Exclusion: severe somatic illness, primary drug or alcohol use disorder, psychiatric diagnosis requiring specialist treatment (i.e., psychosis)
n=946
43±12 y/o
27.2% males
Outpatient setting

Ex: Randomized to 60mins of light (yoga), moderate (intermediate-level aerobics class), or vigorous (higher intensity AEx, REx and balance) exercise

ICBT: Online, self-help manual with weekly interaction with clinician; additional support provided as needed

TAU: Managed by PCP and included pharm and/or CBT, or no treatment
Antidepressants (%)
Ex + TAU: 31%
ICBT + TAU: 31%
CON: 24%

CON: TAU
“Standard tx”: 33%
Pharm: 24%
CBT: NR
No tx: 25%
12 weeks

Ex: 3d/wk/12wks
(36 supervised group sessions)

ICBT: Multiple (self-selected) visits/wk/12wks
(mean of 4 logins/wk and accessed 7.8±5 of 13 modules)

TAU and CON: NR
Ex + TAU (n=317) Ex: 33%
TAU: NR
68(21.5%) Remission: NR
Change in MADRS: 49.1% reduction
ICBT + TAU (n=317) ICBT: 60%
TAU: NR
58(18.3%) Remission: NR
Change in MADRS: 47.9% reduction
CON (n=312) NA 80(25.6%) Remission: NR
Change in MADRS: 34.0% reduction
Schuch et al., 201571 DSM-IV-MINI

Major

Inpatient
Males and females, 18–60y/o, admitted to inpatient facility, HAM-D ≥25, not involved in any other PA during hospitalization
Exclusion: taking beta-blockers, psychiatric diagnosis of bipolar, schizophrenia, anorexia, substance abuse or dependence, 3 or more cardiovascular risk factors on PAR-Q, any medical condition that limits or contraindicates exercise
n=50
40.3±NR y/o
28.0% males
Inpatient setting

AEx: warm-up (stretching 4 lower limb muscle groups and 4min treadmill walk), exercise bout with choice of stationary bike, treadmill, or “transport” machine at 16.5 kcal/kg body mass/wk (~59% HRR), and cool-down

TAU: Pharm and/or ECT and access to OT, but no psych

CON: TAU only
Duration dependent on length of stay

AEx: 3d/wk (average ~23±9d hospitalized)
(Supervised individual sessions)

CON: NR with average ~21±8d hospitalized
AEx + TAU (n=25) AEx: ~91%
TAU: NA
2(8%) Remission: 48%
Response: 84%
CON (n=25) NA 1(4%) Remission: 32%
Response: 60%
Helgadóttir et al., 201672 DSM-IV-MINI

Major, anxiety, comorbid anxiety
Males and females, 18–67 y/o, PHQ-9 ≥10,
Exclusion: primary diagnosis or alcohol or drug dependency, serious somatic disorder, psychiatric diagnosis requiring specialist treatment (i.e., psychosis)
n=620
42.6±12.0 y/o
26.3% males
Outpatient setting

AEx-Vig: 60mins of strenuous group aerobics class

AEx-Mod: 60mins of intermediate-level group aerobics class

AEx-Light: 60mins of yoga-based stretching and balance

TAU: Managed by PCP and included pharm and/or CBT, or no treatment

CON: TAU
12 weeks

AEx groups: 3d/wk/12wks
(36 supervised group sessions and weekly individual session with study personnel)

TAU and CON: NR
AEx-Vig + TAU
(n=99)
AEx: NR
TAU: NA
19(19.2%) Remission: NR
Change in MADRS: 38.4% reduction
AEx-Mod + TAU
(n=105)
AEx: NR
TAU: NA
27(25.7%) Remission: NR
Change in MADRS: 32.9% reduction
AEX-Light + TAU
(n=106)
AEx: NR
TAU: NA
21(19.8%) Remission: NR
Change in MADRS: 44.1% reduction
CON (n=310) NA 79(25.5%) Remission: NR
Change in MADRS: 25.4% reduction
Olson et al., 201773 DSM-IV-MINI

Major
Males and females, 18–30y/o, met non-psychotic depression criteria, no pharm or psych beyond >6wk stable dose of antidepressants or mood stabilizers, no regular exercise or pst mo (<35kcal/kg/day or <3d/wk for ≤20min/session), no physical limitations or contraindications to exercise, normal or corrected-to-normal vision
Exclusion: severe psychopathology (substance dependence, bipolar, schizophrenia disorders), suicidal risk, planned or current pregnancy
n=50
Age: NR
24.0% males
Outpatient setting

AEx: 45mins of steady-state exercise (treadmill or cycle ergometer) at 40–65% HRR

TAU: Stable dose of antidepressants or mood stabilizers permitted, but no psych
~ 14% of sample reported using pharm

CON: 30–45mins of light stretching in sitting and standing
8 weeks

AEx: 3d/wk/8wks
(24 supervised sessions)

TAU: NR

CON: 3d/wk/8wks
(24 supervised sessions)
AEx + TAU (n=25) AEx: 100%
TAU: NR
(only completers reported)
10(40%) 60%
CON + TAU (n=25) NR 10(40%) 33%
Buschert et al., 201974 ICD-10

Unipolar depression

Comorbid: ICD-10 chapters of F4, 5, 6 permitted
Males and females, admitted to inpatient facility with unipolar depression
Exclusion: psychotic symptoms, comorbid psychiatric disorders (except ICD-10 chapters F4, 5, and 6), cardiovascular or neurological disease, cognitive impairment
n=38
41.2±9.1 y/o
36.7% males completed study
Inpatient setting

AEx: 30mins of endurance training (outdoor walking, Nordic walking, running, or stationary cycling) at 85% of APMHR

TAU: Only pharm reported


CON: Additional 30mins OT or AT session
3 to 4 weeks

AEx: 2–3d/wk/3–4wks
(6 –12 supervised group sessions)

TAU: NR

CON: 2–3d/wk/3–4wks
(6 –12 supervised group sessions)
AEx + TAU
(n=20)
Mean sessions: 10.00±3.0 5(25.0%) Remission: NR

Change in
BDI-II: 37.2% reduction
HAM-D7: 34.5% reduction
CON + TAU
(n=18)
Mean sessions: 14.3±8.2 3(16.7%) Remission: NR

Change in
BDI-II: 31.5% reduction
HAM-D7: 33.0% reduction
Chau et al., 202075 ICD-10

Major
(F33.0 – F3.9 ICD-10 codes)
Males and females, 18–64y/o, met ICD-10 diagnosis codes (F33.0–F33.9)
Exclusion: unstable medical or psychological states (suicidal risk), severe cognitive, language or hearing deficits; and orthopedic conditions or other diseases that limit physical fitness assessment
n= 84
47.4±10.6 y/o
20.2% males
Outpatient setting

Ex: 45mins for stretching warmup, circuit training (3 stations of AEx at 50–70% MHR and 3 stations of REx [3×10 reps of each major muscle group]), and 15mins stress management, mindful breathing, stretching, and body awareness (60min total)

TAU: Only pharm noted
Ex: 83%
CON: 83%

CON: TAU waitlist instructed not to initiate structured exercise program
12 weeks

Ex: 3ds/wk/12wks
(36 supervised group sessions)

CON: NA
Ex + TAU (n=42) NR 6(15%) Remission: NR
Change in
HAM-D17: 51.5% reduction
CON + TAU (n=42) NR 7(17.5%) Remission: NR
Change in
HAM-D17: 15.6% reduction
Haussleiter et al., 202076 DSM-IV-SCID

Major
Males and females, admitted for inpatient care, HAM-D ≥17,
Exclusion: Acute suicidality, severe comorbid psychiatric disorders, medical contraindications to PA, cognitive impairment, unable to complete self-administered questionnaires
n=111
per protocol analysis: n=76
45.05±12.19 y/o
33.3% male (full sample)
~68% male (per protocol)
Inpatient setting

GET: 50mins of group exercise of mixed modalities

SOA: Encouraged to perform PA. Meetings to discuss physical conditions, depressive symptoms, and motivational troubles.

TAU: antidepressant and psychoactive medications as prescribed (type and dosage NR)
Mean number of antidepressants
GET: 1.26±0.60
SOA: 1.02±0.73
Mean number of psychoactives
GET: 1.72±1.00
SOA: 2.03±1.14
6 weeks

GET: 3d/wk/6wks
(18 supervised group sessions)

SOA: 3d/wk/6wks (18 supervised group meetings)

TAU: NR
GET + TAU (n=36)
NR Full sample:
Within 3wks: 35 (31.5%)
Baseline to 6wks: NR
HAM-D at 3wks:
Response: 38.9%
Remission: 27.8%
HAM-D at 6wks:
Response: 54.5%
Remission: 40.9%
SOA + TAU (n=40)
NR HAM-D at 3wks:
Response: 25.0%
Remission: 10.0%
HAM-D at 6wks:
Response: 55.6%
Remission: 25.9%

La Rocque et al., 202177 DSM-V-SCID

Unipolar depressive disorder
Females, non-chronic unipolar depressive disorder
Exclusion: psychotic, bipolar, or substance disorder, suicidal intent, medical condition interfering with PA, pregnancy, recent change (<3mos) in pharm or psych, participating in group or yoga exercise bi-weekly or more not obtaining physician clearance with moderate or high risk on PAR-Q
n=53
Per protocol analysis: n=42
~33 y/o
0% males
Outpatient setting

BY: 90mins of instructor-led group Bikram yoga class

AEx: 50–60min group exercise class of choice (choreography-based cardio, aerobics, light muscular conditioning, and stretching; cardio, plyometric, and strength training; high intensity
aerobic exercise with intermittent rest periods; circuit-based cardio and
strength training; stepper-based exercises; and Latin-inspired dance/
fitness)

CON: Waitlist with no interventions

TAU: Continue pharm and/or psych with participant’s own healthcare provider
BY: 8(44.4%)
Pharm: 4(22.2%)
Psych: 3(16.7%)
Both: 1(5.6%)
AEx: 9(45.0%)
Pharm: 4(20.0%)
Psych: 4(20.0%)
Both: 1(5.0%)
CON: 7(46.6%)
Pharm: 7(46.6%)
Psych: 0(0.0%)
Both: 0(0.0%)
8 weeks

BY: 2d/wk/8wks (instructor led group classes)

AEx: 2d/wk/8wks (instructor led group class of choice)

CON: no access to classes

TAU: as prescribed by healthcare provider
BY + TAU (n=18) ITT: 68.8%

Per protocol analysis: 80%
3(16.7%) Remission (ITT): 61%
Response (per protocol): 73.3%
AEx + TAU (n=20) ITT: 66.9%

Per protocol analysis: 86%
5(25.0%) Remission (ITT): 60%
Response
ITT: 60.0%
Per protocol; 80.0%
CON + TAU (n=15) N/A 3(20.0%) Remission: NR
Response
ITT: 6.7%
Per protocol: 8.3%

AEx = aerobic exercise; AEx-Light = exercise-light intensity; AEx-Mod = exercise-moderate intensity; AEx-Vig = exercise-vigorous intensity; APHRM = Age predicted maximum heart rate; AT = art therapy; BDI = Beck Depression Inventory; BMI = body mass index; BRMS = Bech-Rafaelsen Melancholy Scale; BY = bikram yoga; CBT = cognitive behavioral therapy; CIS = Clinical Interview Schedule; CON= control; d = day(s); DSM = Diagnostic and Statistical Manual of Mental Disorders, edition not reported; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition; ECT = electroconvulsive therapy; Ex = exercise; GET = guided exercise therapy; HAM-D = Hamilton Depression Rating Scale; hr(s) = hours(s); HRR = heart rate reserve; ICBT = internet-based cognitive-behavioral therapy; ICD-10 = International Classification of Diseases, 10th Revision; ITT = intention to treat; LO-PA = low intensity physical activity; MADRS = Montgomery A˙sberg Depression Rating Scale; MDI = Major Depression Inventory; MHR = maximum heart rate; min(s) = minute(s); MINI = Mini International Neuropsychiatric Interview; NA= not applicable; NR = not reported; OT = occupational therapy; PA = physical activity; P-AEx = progressive aerobic exercise; PAR-Q = Physical Activity Readiness Questionnaire; PCP = primary care physician; Pharm = pharmacotherapy; PHQ-9: Patient Health Questionare-9; PREx = progressive resistance exercise; Psych = psychotherapy; Relax = relaxation; REx = resistance exercise; RPE = rate of perceived exertion; s = seconds; SCID = Structured Clinical Interview of DSM Disorders; SNRIs = serotonin and norepinephrine reuptake inhibitors; SOA = self-organized activity; SSRIs = selective serotonin reuptake inhibitors; TAU = treatment as usual; VO2max = maximal oxygen uptake; wk(s) = week(s); y/o = years old; 1-RM = one-repetition maximum